Ypsomed signs autoinjector supply deal with Novo Nordisk
Swiss medical technology company Ypsomed announced on Wednesday a long-term supply agreement with Novo Nordisk for autoinjectors, as the Danish drugmaker struggles to keep up with demand for its ne...
Novo Nordisk to establish insulin production in South Africa
Novo Nordisk (NYSE:NVO) wants to produce insulin in South Africa along with a partner to treat diabetics across the African continent, it said. In a statement, the Danish pharmaceutical giant said ...
Novo Nordisk contracts South Africa's Aspen to produce insulin for African nations
Novo Nordisk said on Tuesday is has contracted Aspen Pharmacare to produce human insulin on its behalf in South Africa for export to African countries through a low-cost government tender system.
Novo Nordisk shares fall after media report on quality lapses at US plant
Novo Nordisk, a pharmaceutical company, experienced a decline in its stock prices following a report by financial news agency MarketWire.
Why Novo Nordisk Stock Dipped Today
A media report highlighted the struggles the company has faced in manufacturing its highly popular drug. That drug, Wegovy, is flying off pharmacy shelves thanks to its weight-loss qualities.
Novo Nordisk shares fall after media report about quality lapses at U.S. plant
Novo Nordisk's shares fell on Monday after financial news agency MarketWire reported that U.S. drug regulators had recently issued a report detailing quality control lapses at the group's Clayton, ...
Ozempic maker Novo Nordisk isn't just Europe's second-most valuable company. It is also singlehandedly boosting Denmark's economy.
Ozempic-maker Novo Nordisk is Europe's second-largest company by market capitalization. It's also boosting Denmark's economy all on its own.
Yet Again, Ozempic Could Soon Get Even Better for Novo Nordisk Stock
Ozempic is Novo Nordisk's crown jewel, and it's wildly successful so far. Researchers just found that it could also be useful for treating type 1 diabetes.
3 (Bad) Reasons to Avoid or Sell Novo Nordisk Stock
It's easy to get scared by arguments in favor of selling a stock. Novo Nordisk stock is flying to new heights thanks to its sales of Ozempic.
Novo Nordisk (NVO) Announces Stock Split to Enhance Liquidity
Novo Nordisk (NVO) conducts a two-for-one stock split. While this is already in effect at the stock exchange in Denmark, the ADRs listed on the NYSE will be split in the same ratio by next week.
Novo Nordisk owner invests $290 mln in energy transition fund
The controlling shareholder in drugmaker Novo Nordisk on Thursday announced a major investment in a new energy transition fund as it expands its portfolio beyond health.
Should You Buy Ozempic Maker Novo Nordisk Before Its Stock Split?
Novo Nordisk plans to conduct a 2-for-1 stock split on Sept. 20, increasing share count and reducing share price.
Should You Buy NVO Stock Ahead of the Novo Nordisk Stock Split?
One of today's top trending names is Novo Nordisk (NYSE: NVO ). The Danish pharmaceutical producer has seen its international profile grow this year due to the success of Ozempic.
Novo Nordisk shares slip on two-for-one stock split
Novo Nordisk (NYSE:NVO) shares moved lower after the Denmark-based healthcare company announced its board of directors has approved a two-for-one stock split of its B shares listed on the Nasdaq Co...
Why Is Novo Nordisk (NVO) Stock Up 95% Today?
Novo Nordisk (NYSE: NVO ) stock is on the rise Wednesday after the pharmaceutical company announced a split of its shares. According to a press release from Novo Nordisk, shares of NVO stock are un...
Related Companies